Clinical trial

Switching Strategy With Raltegravir + ABC / 3TC in Controlled HIV-1 Infection

NCT03158077

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2016-11-15

PhaseN/A

Study timeline

Study start (actual)2016-11-15Date precision: day

Registry last updated2017-05-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Sponsors & collaborators

Fundacion SEIMC-GESIDAlead sponsor

Mapped research locations

MadridSpain8 ZaragozaSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03158077 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.